Oncology
短名 | |
Journal Impact | 1.67 |
国际分区 | ONCOLOGY(Q3) |
期刊索引 | SCI Q3中科院 3 区 |
ISSN | 0030-2414, 0890-9091, 1423-0232 |
h-index | 83 |
国内分区 | 医学(3区)医学肿瘤学(4区) |
尽管实验室和临床癌症研究需要紧密联系起来,但基础水平的观察通常仍与医学应用相分离。该杂志致力于加速将实验结果转化为临床,并再次回到实验室进行进一步研究。这项工作的根本目的是提高癌症的临床相关知识,提高恶性疾病的预防、诊断和治疗结果。该杂志发表了来自世界各地癌症项目的重要临床研究,以及重要的转化实验室发现、小型评论(邀请和提交)以及对肿瘤学领域不断发展和有争议的主题的深入讨论。该杂志的一个独特之处是一个新的栏目,专注于快速同行评审和随后发表 1 期和 2 期临床癌症试验的简短报告,旨在确保高质量的临床癌症研究迅速进入公共领域,无论试验关于疗效或毒性的最终结论如何。
期刊主页投稿网址涉及主题 | 医学生物内科学遗传学癌症病理外科化学肿瘤科生物化学免疫学化疗癌症研究 |
出版信息 | 出版商: UBM Medica Healthcare Publications,出版周期: Bimonthly,期刊类型: journal |
基本数据 | 创刊年份: 1987,原创研究文献占比: 96.34%,自引率:4.00%, Gold OA占比: 19.87% |
平均审稿周期 | 网友分享经验:较慢,6-12周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Clinical effects and safety of intra-arterial infusion chemotherapy with lipiodol versus intra-arterial infusion chemotherapy alone for treatment of advanced hepatocellular carcinoma
2024-9-13
Dose-reduction of bevacizumab in atezolizumab plus bevacizumab therapy extends treatment duration with disease control in patients with hepatocellular carcinoma
2024-9-12
The usefulness of serum interleukin-6 as a predictor of response to atezolizumab plus bevacizumab combination treatment in hepatocellular carcinoma
2024-9-12
Clinical impact of skeletal muscle mass and nutritional status in patients with recurrent or advanced gastric cancer treated with nivolumab
2024-9-12
Social characteristics of culturally and linguistically diverse cancer patients enrolled in early phase clinical trials in South-Western Sydney
2024-9-12
Identification of biomarkers for assessing treatment efficacy of chemotherapy plus nivolumab as the first line in patients with unresectable advanced or recurrent gastric cancer: a multicenter study
2024-9-12
A Scoping Review of Population Diversity in the Common Genomic Aberrations of Clear Cell Renal Cell Carcinoma
2024-9-9
Clinicopathological factors predicting pathological complete response to neoadjuvant anti-HER2 therapy in HER2-positive breast cancer
2024-9-9
A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer
2024-9-5
Development of a diagnostic model for pancreatic ductal adenocarcinoma using machine learning and blood-based miRNAs
2024-9-4
Utility of assessing early tumor shrinkage as an efficacy predictor in patients with non–surgically indicated or recurrent esophageal cancer treated with nivolumab plus ipilimumab
2024-8-29
ASSOCIATION OF INSULIN RECEPTOR SUBSTRATE 1 (IRS 1) EXPRESSION IN THE PROGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA - A SYSTEMATIC REVIEW AND META ANALYSIS
2024-8-26
Pulmonary adenocarcinoma with enteric differentiation (PAED) without TTF-1 expression is a very rare subtype with limited treatment options and poor prognosis
2024-8-19
Long-term Survival Outcomes and Risk Factors for Axillary and Locoregional Recurrence in Japanese Patients with Sentinel Node–positive Breast Cancer Treated in Accordance with the ACOSOG Z0011 Strategy
2024-8-19
Identification and initial validation of neuroendocrine differentiation as a novel prognostic factor in stage II colorectal cancer patients
2024-8-19
Claudin-1 in head and neck squamous cell carcinoma
2024-8-14
Assessment of Cardiovascular Events Caused by New Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan
2024-8-14
Significance of gene polymorphism and gene expression of BACE2 in Swedish patients with colorectal cancer
2024-8-14
How to prevent local recurrence of sacral chordoma treated with carbon-ion radiotherapy: An analysis of the risk factors of local failure and an adequate disease margin
2024-8-12
High expression of cancer-derived sialylated immunoglobulin G: a novel biomarker for poor prognosis in laryngeal squamous cell carcinoma
2024-8-12
The overexpressed microRNAs miRs-182, 155, 493, 454 and U6 snRNA, and underexpressed let-7c, miR-328 and miR-451a as potential biomarkers in invasive breast cancer and their clinicopathological significance
2024-8-12
Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib
2024-8-5
The Glasgow Prognostic Score as a Predictor of Survival After Chemoradiotherapy for Limited-Disease Small Cell Lung Cancer
2024-8-5
Chronic Lymphocytic Leukemia in Pregnancy: A Review of the Available Literature and the Pharmacological Challenges in Management
2024-7-31
The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer
2024-7-30
Interleukin-7 risk allele, lymphocyte counts, and autoantibodies for prediction of risk of immune-related adverse events in patients receiving Atezolizumab plus Bevacizumab therapy for unresectable hepatocellular carcinoma
2024-7-30
Effect of Hydration with Bicarbonate Ringer’s Solution on Cisplatin-Induced Acute Kidney Injury in Patients with Esophageal Cancer: A Retrospective Cohort Study
2024-7-29
Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas
2024-7-25
Integrating AI-driven Wearable Technology in Oncology Decision Making: A Narrative Review
2024-7-25
Ubiquitin-Specific Protease 52 as a Prognostic Biomarker Correlates with Tumor Microenvironment and Therapy Response in Colorectal Cancer
2024-7-24
Changes in mutations of cell-free DNA and liver tumor tissue in patients with advanced hepatocellular carcinoma before and after introduction of lenvatinib
2024-7-24
SIRT1 promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma.
2024-7-22
Factors affecting recurrence and survival in Stage IIA colon cancer patients
2024-7-22
Artificial Intelligence-driven Prediction Revealed CFTR Associated With Therapy Outcome Of Breast Cancer: A Feasibility Study
2024-7-18
Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study
2024-7-17
Serum Uric Acid Level May Be a Predictive Factor for BRAF V600E Mutation in Older Patients with Metastatic Colorectal Cancer: An Exploratory Analysis
2024-7-17
Zinc Supplementation in Head and Neck Cancer: Prevention of Chemo-Radio-Induced Complications and an Opportunity for Treatment
2024-7-17
Experience and prognostic analysis with avelumab switch maintenance treatment in metastatic urothelial carcinoma
2024-7-17
Chronic Myeloid Leukemia in Adolescents and Young Adults: Clinicopathological Variables and Outcomes.
2024-7-16
Relationship between Anaplastic Lymphoma Kinase (ALK) Inhibitors and Epileptic Seizure Disorder: A Post-Marketing Surveillance Study.
2024-5-20
Paraneoplastic Hyperthyroidism in advanced testicular non-seminomatous germ cell tumors: Prevalence and clinical Management
2024-5-6
Myocardial Infarction in Chronic Myeloid Leukemia: Results from Nationwide Readmission Database
2024-5-3
Comprehensive Genomic Characterization in Ovarian Low-Grade and chemosensitive and chemoresistant High-Grade Serous Carcinomas
2024-5-3
Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma
2024-3-25
Potential of Using qFibrosis Analysis to Predict Recurrent and Survival Outcome of Patients with Hepatocellular Carcinoma after Hepatic Resection
2024-3-25
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
2024-3-12
Decision-Making at Swissmedic, the Swiss Regulatory Agency, with a Focus on (Neo)adjuvant Cancer Treatments
2024-3-5
Nesprin1 Deficiency Is Associated with Poor Prognosis of Renal Cell Carcinoma and Resistance to Sunitinib Treatment
2024-3-5
Comprehensive Study of Chromosomal Copy Number Variations and Genomic Variations Predicting Overall Survival in Myelodysplastic Syndromes
2024-3-5
Arterial-Portal Venous Shunt after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma Patients: Risk factors and Impact on Patient Survival
2024-2-26
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远